Fox Chase Cancer Center

Futó vizsgálatok

• Toboroz

  Risk-Enabled Therapy After Initiating EV/Pembro for Bladder Cancer

  NCT07908979· 2. fázis· Fox Chase Cancer Center· Forrás

• Toboroz

  A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma

  NCT07768189· 3. fázis· Corbus Pharmaceuticals Inc.· Forrás

• Toboroz

  Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Advanced Head and Neck Cancer Who Cannot Receive Cisplatin

  NCT07441681· 3. fázis· NRG Oncology· Forrás

• Toboroz

  Prehabilitation in High-risk Oncologic Surgery

  NCT07638410· Fox Chase Cancer Center· Forrás

• Még nem toboroz

  AUR103 Calcium in Advanced Neuroendocrine Tumours (BHARAT-3 Study)

  NCT07640737· 2. fázis· Aurigene Discovery Technologies Limited· Forrás

• Toboroz

  A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

  NCT07542704· 1. fázis· Kumquat Biosciences Inc.· Forrás

• Toboroz

  INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)

  NCT07429266· 3. fázis· Ono Pharmaceutical Co., Ltd.· Forrás

• Toboroz

  A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions

  NCT07422480· 3. fázis· Takeda· Forrás

• Toboroz

  A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

  NCT07419295· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

  NCT07068074· 3. fázis· ECOG-ACRIN Cancer Research Group· Forrás

• Toboroz

  Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas

  NCT07455032· 1. fázis· Fox Chase Cancer Center· Forrás

• Toboroz

  Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer

  NCT07057791· 2. fázis· PrECOG, LLC.· Forrás

• Toboroz

  A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

  NCT07258511· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  Pembrolizumab Maintenance After Enfortumab Vedotin (EV)/Pembro Induction in Front-Line Metastatic Urothelial Carcinoma

  NCT07221942· 2. fázis· Fox Chase Cancer Center· Forrás

• Toboroz

  A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

  NCT07195682· 1. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

  NCT07185997· 3. fázis· ArriVent BioPharma, Inc.· Forrás

• Toboroz

  A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

  NCT07276399· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

  NCT07061977· 3. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis

  NCT06794229· 2. fázis· Qian Qin· Forrás

• Toboroz

  Adaptive Radiation Boost for Rectal Cancer

  NCT07221058· 1. fázis· Fox Chase Cancer Center· Forrás

• Toboroz

  A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

  NCT07213791· 1. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy

  NCT07167446· Korai 1. fázis· Fox Chase Cancer Center· Forrás

• Toboroz

  A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

  NCT06973187· 3. fázis· BeOne Medicines· Forrás

• Toboroz

  Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

  NCT06966024· 1. fázis· Deciphera Pharmaceuticals, LLC· Forrás

• Toboroz

  Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer

  NCT06984562· Fox Chase Cancer Center· Forrás

• Toboroz

  Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Upper Tract Urothelial Cancer

  NCT06356155· 2. fázis· University of Michigan Rogel Cancer Center· Forrás

• Toboroz

  Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

  NCT07000084· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás

• Toboroz

  Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma

  NCT07043972· 2. fázis· Fox Chase Cancer Center· Forrás

• Fut, nem toboroz

  An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

  NCT06991556· 2. fázis· Novartis Pharmaceuticals· Forrás

• Fut, nem toboroz

  CLOVER - CCR5-targeting Leronlimab With Oral Chemotherapy and VEGF-inhibitor Enriched Regimen

  NCT06699836· 2. fázis· CytoDyn, Inc.· Forrás

• Toboroz

  A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

  NCT06852222· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  NCT06616584· 2/3. fázis· SWOG Cancer Research Network· Forrás

• Toboroz

  SLV-154 Treatment of Advanced Cancers

  NCT06771219· 1. fázis· Solve Therapeutics· Forrás

• Toboroz

  Enfortumab Vedotin Plus Pembrolizumab With Selective Bladder Sparing for Treatment of Muscle-invasive Bladder Cancer

  NCT06809140· 2. fázis· Matthew Galsky· Forrás

• Toboroz

  A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

  NCT06778863· 1. fázis· Clasp Therapeutics, Inc.· Forrás

• Toboroz

  Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

  NCT06780670· 2/3. fázis· Novartis Pharmaceuticals· Forrás

• Fut, nem toboroz

  Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer

  NCT06619236· 3. fázis· Genmab· Forrás

• Fut, nem toboroz

  A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors

  NCT06777316· 1/2. fázis· Cogent Biosciences, Inc.· Forrás

• Toboroz

  SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma

  NCT06743126· 3. fázis· Immatics US, Inc.· Forrás

• Toboroz

  Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy

  NCT06660355· 2. fázis· H. Lee Moffitt Cancer Center and Research Institute· Forrás

• Toboroz

  A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

  NCT06750094· 3. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)

  NCT06691984· 3. fázis· Amgen· Forrás

• Toboroz

  Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

  NCT06337318· 3. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

  NCT06662786· 3. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer

  NCT06497556· 3. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).

  NCT06333951· 1. fázis· Amgen· Forrás

• Toboroz

  Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

  NCT06422806· 3. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

  NCT06246916· 3. fázis· Regeneron Pharmaceuticals· Forrás

• Toboroz

  Reducing Urban Cervical Cancer Disparities

  NCT06416150· Fox Chase Cancer Center· Forrás

• Toboroz

  Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE)

  NCT06396533· Fox Chase Cancer Center· Forrás

Showing 50 of 231.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák16 toboroz
• Hólyagrák12 toboroz
• Fej-nyaki daganatok10 toboroz
• Vastagbélrák9 toboroz
• Melanóma8 toboroz
• Gyermekkori daganatok7 toboroz
• Petefészekrák7 toboroz
• Hasnyálmirigyrák6 toboroz
• Prosztatarák5 toboroz
• Szarkóma4 toboroz
• Gyomor- és nyelőcsőrák3 toboroz
• Méhnyakrák3 toboroz
• Neuroendokrin daganatok3 toboroz
• Vesedaganat3 toboroz
• Mielóma multiplex2 toboroz
• Mieloproliferatív neopláziák2 toboroz
• Akut mieloid leukémia (AML)1 toboroz
• Áttétes emlőrák1 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)1 toboroz
• Follikuláris limfóma1 toboroz
• Krónikus limfoid leukémia (CLL)1 toboroz
• Krónikus mieloid leukémia (CML)1 toboroz
• Máj- és epeúti rák1 toboroz
• Méhtestrák1 toboroz
• Mielodiszplasztikus szindróma (MDS)1 toboroz

Lezárt vizsgálatok

• Leállították

  Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

  NCT06790966· 3. fázis· PDS Biotechnology Corp.· Forrás

• Toboroz

  A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

  NCT06515613· 1. fázis· Context Therapeutics Inc.· Forrás

• Lezárult

  Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study

  NCT06234488· Medical College of Wisconsin· Forrás

• Leállították

  Phase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCL

  NCT05883449· 2. fázis· Affimed GmbH· Forrás

• Lezárult

  HPV Self-sampling for Underscreened Latinas

  NCT06439706· Fox Chase Cancer Center· Forrás

• Leállították

  Prime-boost Immunotherapeutic Trial in Men With Biochemical Recurrence After Definitive Local Therapy for Prostate Cancer

  NCT05617040· 1/2. fázis· Barinthus Biotherapeutics· Forrás

• Leállították

  Iadademstat in Combination With Paclitaxel in Relapsed/Refractory SCLC and Extrapulmonary High Grade NET

  NCT05420636· 2. fázis· Fox Chase Cancer Center· Forrás

• Lezárult

  GCC Agonist Signal in the Small Intestine

  NCT05107219· 1. fázis· University of Wisconsin, Madison· Forrás

• Lezárult

  African Cancer Genome: GMD

  NCT05754658· Fox Chase Cancer Center· Forrás

• Lezárult

  Study of DF9001 in Patients With Advanced Solid Tumors

  NCT05597839· 1/2. fázis· Dragonfly Therapeutics· Forrás

• Lezárult

  Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

  NCT05287113· 2. fázis· Incyte Biosciences International Sàrl· Forrás

• Visszavonták

  Sotorasib in KRAS G12C Mutated, Resectable, Stage Ib-IIIA NSCLC

  NCT05400577· 2. fázis· Fox Chase Cancer Center· Forrás

• Leállították

  Study of Magrolimab Versus Placebo in Combination With Venetoclax and Azacitidine in Participants With Acute Myeloid Leukemia

  NCT05079230· 3. fázis· Gilead Sciences· Forrás

• Leállították

  A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors

  NCT05070247· 1/2. fázis· Takeda· Forrás

• Leállították

  A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene Alterations

  NCT05242822· 1. fázis· Kinnate Biopharma· Forrás

• Leállították

  NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors

  NCT05252390· 1. fázis· Nuvation Bio Inc.· Forrás

• Lezárult

  Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue

  NCT04972097· Angiodynamics, Inc.· Forrás

• Leállították

  A Study of the Effects of AB-205 in Patients With Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation

  NCT05181540· 3. fázis· Angiocrine Bioscience· Forrás

• Lezárult

  A Study of PRT2527 in Participants With Advanced Solid Tumors

  NCT05159518· 1. fázis· Prelude Therapeutics Incorporated· Forrás

• Toboroz

  A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer

  NCT05125016· 1/2. fázis· Regeneron Pharmaceuticals· Forrás

• Lezárult

  A Study to Learn About the Study Medicine (Elranatamab) in Participants With Multiple Myeloma That Has Come Back After Responding to Treatment or Has Not Responded to Treatment

  NCT05014412· 2. fázis· Pfizer· Forrás

• Leállították

  KZR-261 in Subjects With Advanced Solid Malignancies

  NCT05047536· 1. fázis· Kezar Life Sciences, Inc.· Forrás

• Leállították

  Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement

  NCT04221438· 2. fázis· ECOG-ACRIN Cancer Research Group· Forrás

• Visszavonták

  Local Consolidative Therapy in Colorectal Cancer

  NCT05062720· 2. fázis· Fox Chase Cancer Center· Forrás

• Lezárult

  PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy 2

  NCT04815876· Weill Medical College of Cornell University· Forrás

• Toboroz

  A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)

  NCT04811560· 1/2. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 3)

  NCT04880434· 2. fázis· Kite, A Gilead Company· Forrás

• Lezárult

  Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC

  NCT04260126· 2. fázis· PDS Biotechnology Corp.· Forrás

• Lezárult

  Pembrolizumab Plus Lenvatinib for First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (1L nccRCC) (MK-3475-B61)

  NCT04704219· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb

  NCT04649359· 2. fázis· Pfizer· Forrás

• Lezárult

  A Study of Avutometinib (VS-6766) + Defactinib in Recurrent KRAS G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer

  NCT04620330· 2. fázis· Verastem, Inc.· Forrás

• Toboroz

  Collection of Samples USOPTIVAL Study

  NCT04792684· Universal Diagnostics· Forrás

• Lezárult

  The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC

  NCT04338399· 3. fázis· Adlai Nortye Biopharma Co., Ltd.· Forrás

• Lezárult

  Study of CG0070 Given in Combination With Pembrolizumab, in Non-Muscle Invasive Bladder Cancer, Unresponsive to Bacillus Calmette-Guerin

  NCT04387461· 2. fázis· CG Oncology, Inc.· Forrás

• Leállították

  Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

  NCT04383210· 2. fázis· Elevation Oncology· Forrás

• Lezárult

  A Study of Belzutifan (MK-6482) in Participants With Advanced Renal Cell Carcinoma (MK-6482-013)

  NCT04489771· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors

  NCT04526106· 1/2. fázis· Elevar Therapeutics· Forrás

• Leállították

  A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX)

  NCT04459715· 3. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Lezárult

  Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009)

  NCT04428151· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Leállították

  Futibatinib in Patients With Specific FGFR Aberrations

  NCT04189445· 2. fázis· Taiho Oncology, Inc.· Forrás

• Leállították

  A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment

  NCT04338269· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

  NCT04332653· 1/2. fázis· NeoImmuneTech· Forrás

• Lezárult

  A Study of Oral Venetoclax Tablets and Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy

  NCT04102020· 3. fázis· AbbVie· Forrás

• Leállították

  A Study of TAS1440 With ATRA in Subjects With r/r AML

  NCT04282668· 1. fázis· Taiho Oncology, Inc.· Forrás

• Lezárult

  Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial)

  NCT04173507· 2. fázis· SWOG Cancer Research Network· Forrás

• Lezárult

  A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression

  NCT04209855· 3. fázis· AbbVie· Forrás

• Lezárult

  TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study

  NCT04109924· 2. fázis· Roswell Park Cancer Institute· Forrás

• Lezárult

  Safety and Efficacy of SB 11285 Alone and in Combination With Atezolizumab in Patients With Advanced Solid Tumors

  NCT04096638· 1. fázis· invoX Pharma Limited· Forrás

• Lezárult

  A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

  NCT03929666· 2. fázis· Jazz Pharmaceuticals· Forrás

• Leállították

  Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer

  NCT03737994· 2. fázis· National Cancer Institute (NCI)· Forrás

Showing 50 of 108.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Hólyagrák28 munka · 32 vizsgálat
• Vesedaganat27 munka · 21 vizsgálat
• Hodgkin-limfóma14 munka · 8 vizsgálat
• Fej-nyaki daganatok11 munka · 38 vizsgálat
• Köpenysejtes limfóma9 munka · 4 vizsgálat